Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans
Condition:   Crimean-Congo Hemorrhagic Fever Interventions:   Biological: KIRIM-KONGO-VAX;   Other: Placebo Sponsors:   Tubitak;   MonitorCRO Active, not recruiting - verified January 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2017 Category: Research Source Type: clinical trials